Myriam Vilasco Gamberoni

Early Asset Medical Affairs Lead @AstraZeneca

Paris, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2024 — Present

Early Asset Medical Affairs Lead @AstraZeneca

View department →

Courbevoie, FR

EDUCATION

2005 — 2008

Université Paris Cité

Doctor of Molecular Biology, Cell/Cellular and Molecular Biology and Virology

2012 — 2013

ESSEC Business School

Executive Master, Master of Strategy and Management of Health Industry

SKILLS

Cell CultureWestern BlottingCell BiologyVirologyBiochemistryInnate ImmunityPcrImmunologyGraphpad PrismIn VivoCancerTransfectionMicroarray AnalysisIn VitroMolecular Biology

ABOUT MYRIAM VILASCO GAMBERONI

Long term scientific partnerships. Technology Transfer: elaboration and negotiation of i) scientific collaborations between academics and industrials, and ii) patent licensing. Acquired extensive research experience in molecular biology. Gained in depth proficiency in scientific concepts and terminology. Self-motivated, organized and resourceful. Strong work ethics and integrity. High tolerance to stress and excellent multi-tasking skills. Various computer software applications: MS Office, EndNote Adobe Photoshop, Prism 5. Specialties Molecular Biology Virology Innate Immunity Oncology Glucocorticoid Signaling

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Myriam Vilasco Gamberoni — Early Asset Medical Affairs Lead at AstraZeneca in Paris, FR | Unifers